Erik Rasmussen
- Molecular Biology top 5%
- Oncology top 1%
- Hematology top 0.5%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Co-authors
- Bart BarlogieJohn D. ShaughnessyRonald C. WalkerFenghuang ZhanErming TianYupo MaRichard D. ToddRosalind J. Neuman
- Topics
- Multiple Myeloma Research and Treatments (23 papers)CAR-T cell therapy research (14 papers)Cancer Immunotherapy and Biomarkers (11 papers)
- Cited by
- HematologyOncologyMolecular Biology
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Erik Rasmussen
102 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Molecular Biology 2.2k
- Oncology 2.0k
- Hematology 1.4k
- Pulmonary and Respiratory Medicine 552
- Immunology 539
Countries citing papers authored by Erik Rasmussen
This map shows the geographic impact of Erik Rasmussen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Rasmussen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Rasmussen more than expected).
Fields of papers citing papers by Erik Rasmussen
This network shows the impact of papers produced by Erik Rasmussen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Rasmussen. The network helps show where Erik Rasmussen may publish in the future.
Co-authorship network of co-authors of Erik Rasmussen
This figure shows the co-authorship network connecting the top 25 collaborators of Erik Rasmussen. A scholar is included among the top collaborators of Erik Rasmussen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Rasmussen. Erik Rasmussen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 11 | |
| 3 | 44 | |
| 4 | 3 | |
| 5 | 30 | |
| 6 | 45 | |
| 7 | 62 | |
| 8 | 33 | |
| 9 | 157 | |
| 10 | 16 | |
| 11 | 63 | |
| 12 | 34 | |
| 13 | 43 | |
| 14 | 10 | |
| 15 | 1 | |
| 16 | Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myelomabreakdown → | 532 |
| 17 | 95 | |
| 18 | 141 | |
| 19 | 68 | |
| 20 | 37 |
About Erik Rasmussen
Erik Rasmussen is a scholar working on Hematology, Oncology and Cancer Research, having authored 107 papers that have together received 4.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (23 papers), CAR-T cell therapy research (14 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Hematology (1.4k citations), Oncology (2.0k citations) and Molecular Biology (2.2k citations). Erik Rasmussen has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Bart Barlogie, John D. Shaughnessy, Ronald C. Walker, Fenghuang Zhan, Erming Tian, Yupo Ma, Richard D. Todd, Rosalind J. Neuman, Andrew C. Heath and Guido Tricot. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.